{"id":9471,"date":"2026-04-01T13:58:49","date_gmt":"2026-04-01T05:58:49","guid":{"rendered":"https:\/\/chimebiologics.com\/?p=9471"},"modified":"2026-04-01T14:58:44","modified_gmt":"2026-04-01T06:58:44","slug":"bioequity-europe-2026","status":"publish","type":"post","link":"https:\/\/chimebiologics.com\/ja\/bioequity-europe-2026\/","title":{"rendered":"(English) BioEquity Europe 2026"},"content":{"rendered":"

\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000English<\/a>\u3068 \u4e2d\u6587<\/a>\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p>


\n<\/p>\n

BioEquity Europe 2026<\/strong><\/h1>\n

May 5, 2026<\/p>\n

<\/div>\n

<\/p>\n<\/div><\/section>
\n

\"\"<\/p>\n<\/div><\/section><\/p><\/div>

<\/p>\n

<\/p>\n\n\n\n\n\n\n
Date<\/b><\/strong><\/td>\nMay 5, 2026<\/td>\n<\/tr>\n
Time<\/b><\/strong><\/td>\n07:30 \u2013 08:30 (UTC+2)<\/td>\n<\/tr>\n
Location<\/b><\/strong><\/td>\nPrague, Czech Republic<\/td>\n<\/tr>\n
Address<\/b><\/strong><\/td>\n5. kv\u011btna 1640\/65, 140 21 Praha 4-Nusle, Czech Republic<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Europe's biotechs can boost asset appeal by adopting \"China speed\"\u2014using efficient CDMOs to generate first-in-human data faster, shaping early development to drive partnering and valuation. With faster timelines and lower costs from preclinical to approval, Western leaders should leverage China to de-risk assets quickly. This workshop explores China\u2019s development and manufacturing strategy.<\/p>\n

<\/p>\n<\/div><\/section><\/p>\n

<\/p>\n

Save the Date<\/span><\/div>\n
<\/div>\n

<\/p>\n<\/div><\/section>\n

\n
mk-form-event<\/div>\n<\/div>\n<\/div><\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":9472,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55,51,1],"tags":[],"class_list":["post-9471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event","category-newsroom","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/9471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/comments?post=9471"}],"version-history":[{"count":3,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/9471\/revisions"}],"predecessor-version":[{"id":9475,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/posts\/9471\/revisions\/9475"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/media\/9472"}],"wp:attachment":[{"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/media?parent=9471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/categories?post=9471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chimebiologics.com\/ja\/wp-json\/wp\/v2\/tags?post=9471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}